| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.06 | 0.5 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |